サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1225527

COPD・喘息用デバイス市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年の予測

COPD and Asthma Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
COPD・喘息用デバイス市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年の予測
出版日: 2023年02月03日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要

  • COPDおよび喘息用デバイスの世界市場規模は、2022年に434億米ドルに達しました。今後、IMARCグループは、2023年から2028年の間に5.31%の成長率（CAGR）を示し、2028年までに604億米ドルに達すると予測しています。
  • 慢性閉塞性肺疾患（COPD）は、肺からの気流が阻害される炎症性疾患です。初期症状としては、息切れ、喘鳴、胸の圧迫感、粘液を伴うまたは伴わない慢性的な咳、頻繁な風邪、喉の痛みなどがあります。一方、喘息は気管支喘息とも呼ばれ、肺の気道が侵される呼吸器疾患です。その症状は、息切れ、胸の圧迫感、睡眠障害、咳や喘鳴発作などです。これらの呼吸器疾患の治療には、吸入薬を投与するためのさまざまな機器が用いられます。COPDや喘息治療器は、肺ドラッグデリバリーデバイスとも呼ばれ、呼吸器疾患の永続的な治療や救援療法として使用されています。その結果、世界中で絶大な支持を獲得しています。

COPDおよび喘息用デバイスの市場動向

  • 慢性呼吸器疾患に罹患しやすい高齢者人口の増加が、市場にプラスの影響を与える重要な要因の1つとなっています。また、タバコの喫煙量の増加別呼吸器疾患の発生が、COPDおよび喘息デバイスの売上を増加させています。これとは別に、ヘルスケアへの支出の増加やヘルスケア産業における継続的な自動化が、市場の成長に寄与しています。高度な医療ソリューションの普及は、世界中のメーカーに有利な成長機会を提供しています。現在、ヘルスケア専門医や肺疾患専門医は、迅速かつ効果的な結果を得るために、薬剤とデバイスの組み合わせを好んで使用しています。さらに、化学産業の拡大により、環境汚染レベルや呼吸の問題が増加しており、これが市場を牽引しています。さらに、携帯型ドラッグデリバリーデバイスのイントロダクションが市場の成長を促進しています。

主な市場セグメンテーション

  • IMARC Groupは、世界のCOPDおよび喘息デバイス市場レポートの各サブセグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を行っています。当レポートでは、製品、適応症、流通チャネルに基づき、市場を分類しています。

製品別の内訳

  • 吸入器
  • 薬剤粉末吸入器（DPI）
  • 定量噴霧式吸入器（MDI）
  • ソフトミスト吸入器
  • ネブライザー
  • コンプレッサーネブライザー
  • 超音波ネブライザー
  • メッシュネブライザー

効能別の内訳

  • 気管支喘息
  • COPD

販売チャネル別内訳

  • 小売薬局
  • 病院
  • オンライン薬局

地域別の内訳

  • 北米
  • 米国
  • カナダ
  • アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
  • 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
  • 中東とアフリカ

本レポートで回答した主な質問

  • COPDおよび喘息デバイスの世界市場はこれまでどのように推移し、今後数年間はどのように推移するのでしょうか？
  • COVID-19は世界のCOPDおよび喘息デバイス市場にどのような影響を及ぼしましたか？
  • 主要な地域市場とは？
  • 製品に基づく市場の内訳は？
  • 適応症に基づく市場の内訳は？
  • 販売チャネルに基づく市場の内訳は？
  • 業界のバリューチェーンにおける様々なステージとは？
  • 業界における主要な促進要因と課題は何か？
  • 世界のCOPDおよび喘息治療器市場の構造および主要プレイヤーは？
  • 業界における競合の度合いとは？

目次

第1章 序文

第2章 調査手法と範囲

  • 調査の目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な産業動向

第5章 COPDと喘息用デバイスの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 製品別市場内訳

  • 吸入器
    • 市場動向
    • 主要セグメント
      • 薬剤粉末吸入器（DPI）
      • 定量噴霧式吸入器（MDI）
      • ソフトミスト吸入器
    • 市場予測
  • ネブライザー
    • 市場動向
    • 主要セグメント
      • コンプレッサー式ネブライザー
      • 超音波ネブライザー
      • メッシュ式ネブライザー
    • 市場予測

第7章 適応症別市場内訳

  • 気管支喘息
    • 市場動向
    • 市場予測
  • COPD
    • 市場動向
    • 市場予測

第8章 流通チャネル別市場内訳

  • 小売薬局
    • 市場動向
    • 市場予測
  • 病院
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測

第9章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場展望
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場展望
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場展望
    • 韓国市場
      • 市場動向
      • 市場展望
    • オーストラリア
      • 市場動向
      • 市場展望
    • インドネシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場展望
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場展望
    • スペイン
      • 市場動向
      • 市場展望
    • ロシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場展望
    • メキシコ
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターズファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競争情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Adherium Limited
    • Aristopharma Ltd.
    • AstraZeneca PLC
    • Baxter International Inc.
    • Boehringer Ingelheim International GmbH
    • Cohero Health Inc.
    • Koninklijke Philips N.V.
    • Omron Corporation
    • Pari Respiratory Equipment Inc.
    • Recipharm AB
    • Verona Pharma plc
図表

List of Figures

  • Figure 1: Global: COPD and Asthma Devices Market: Major Drivers and Challenges
  • Figure 2: Global: COPD and Asthma Devices Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: COPD and Asthma Devices Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: COPD and Asthma Devices Market: Breakup by Product (in %), 2022
  • Figure 5: Global: COPD and Asthma Devices Market: Breakup by Indication (in %), 2022
  • Figure 6: Global: COPD and Asthma Devices Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: COPD and Asthma Devices Market: Breakup by Region (in %), 2022
  • Figure 8: Global: COPD and Asthma Devices (Inhalers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: COPD and Asthma Devices (Inhalers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: COPD and Asthma Devices (Nebulizers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: COPD and Asthma Devices (Nebulizers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: COPD and Asthma Devices (Asthma) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: COPD and Asthma Devices (Asthma) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: COPD and Asthma Devices (COPD) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: COPD and Asthma Devices (COPD) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: COPD and Asthma Devices (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: COPD and Asthma Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: COPD and Asthma Devices (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: COPD and Asthma Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: COPD and Asthma Devices (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: COPD and Asthma Devices (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: North America: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: North America: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: United States: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: United States: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Canada: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Canada: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Asia-Pacific: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Asia-Pacific: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: China: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: China: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Japan: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Japan: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: India: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: India: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: South Korea: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: South Korea: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Australia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Australia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Indonesia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Indonesia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Europe: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Europe: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Germany: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Germany: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: France: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: France: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: United Kingdom: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: United Kingdom: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Italy: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Italy: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Spain: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Spain: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Russia: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Russia: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Latin America: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Latin America: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Brazil: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Brazil: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Mexico: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Mexico: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Middle East and Africa: COPD and Asthma Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Middle East and Africa: COPD and Asthma Devices Market: Breakup by Country (in %), 2022
  • Figure 70: Middle East and Africa: COPD and Asthma Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Global: COPD and Asthma Devices Industry: SWOT Analysis
  • Figure 72: Global: COPD and Asthma Devices Industry: Value Chain Analysis
  • Figure 73: Global: COPD and Asthma Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: COPD and Asthma Devices Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: COPD and Asthma Devices Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: COPD and Asthma Devices Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 4: Global: COPD and Asthma Devices Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: COPD and Asthma Devices Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: COPD and Asthma Devices Market: Competitive Structure
  • Table 7: Global: COPD and Asthma Devices Market: Key Players
目次
Product Code: SR1423A368_Report

Market Overview:

  • The global COPD and asthma devices market size reached US$ 43.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 60.4 Billion by 2028, exhibiting a growth rate (CAGR) of 5.31% during 2023-2028.
  • Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness. On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.

COPD and Asthma Devices Market Trends:

  • The growing global geriatric population, which is highly susceptible to chronic respiratory disorders, represents one of the key factors positively influencing the market. In addition, rising occurrences of respiratory diseases caused due to the rising smoking of cigarettes are increasing the sales of COPD and asthma devices. Apart from this, the increasing expenditure on healthcare and continuous automation in the healthcare industry are contributing to the market growth. The widespread adoption of advanced medical solutions is offering lucrative growth opportunities to manufacturers across the globe. At present, healthcare practitioners and pulmonary diseases specialists are preferring a combination of a drug and a device on account of their fast and effective outcome. Furthermore, the expansion of chemical industries is resulting in the rising environmental pollution level and breathing problems, which, in turn, is driving the market. Additionally, the introduction of portable drug delivery devices is propelling the market growth.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global COPD and asthma devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, indication and distribution channel.

Breakup by Product:

  • Inhalers
  • Drug Powdered Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Soft Mist Inhalers
  • Nebulizers
  • Compressor Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

Breakup by Indication:

  • Asthma
  • COPD

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospitals
  • Online Pharmacies

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Adherium Limited, Aristopharma Ltd., AstraZeneca PLC, Baxter International Inc., Boehringer Ingelheim International GmbH, Cohero Health Inc., Koninklijke Philips N.V., Omron Corporation, Pari Respiratory Equipment Inc., Recipharm AB and Verona Pharma plc.

Key Questions Answered in This Report:

  • How has the global COPD and asthma devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global COPD and asthma devices market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global COPD and asthma devices market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global COPD and Asthma Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Inhalers
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Drug Powdered Inhalers (DPIs)
      • 6.1.2.2 Metered Dose Inhalers (MDIs)
      • 6.1.2.3 Soft Mist Inhalers
    • 6.1.3 Market Forecast
  • 6.2 Nebulizers
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Compressor Nebulizers
      • 6.2.2.2 Ultrasonic Nebulizers
      • 6.2.2.3 Mesh Nebulizers
    • 6.2.3 Market Forecast

7 Market Breakup by Indication

  • 7.1 Asthma
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 COPD
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Adherium Limited
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Aristopharma Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 AstraZeneca PLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Baxter International Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Boehringer Ingelheim International GmbH
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Cohero Health Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Koninklijke Philips N.V.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Omron Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pari Respiratory Equipment Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Recipharm AB
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Verona Pharma plc
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis